Breast Cancer After Treatment of Differentiated Thyroid Cancer With Radioiodine in Young Females: What We Know and How to Investigate Open Questions. Review of the Literature and Results of a Multi-Registry Survey

Published studies on the risk of radiation-induced second primary malignancy (SPM) after radioiodine treatment (RAI) of differentiated thyroid cancer (DTC) refer mainly to patients treated as middle-aged or older adults and are not easily generalizable to those treated at a younger age. Here we revi...

Descripción completa

Detalles Bibliográficos
Autores principales: Reiners, Christoph, Schneider, Rita, Platonova, Tamara, Fridman, Mikhail, Malzahn, Uwe, Mäder, Uwe, Vrachimis, Alexis, Bogdanova, Tatiana, Krajewska, Jolanta, Elisei, Rossella, Vaisman, Fernanda, Mihailovic, Jasna, Costa, Gracinda, Drozd, Valentina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381297/
https://www.ncbi.nlm.nih.gov/pubmed/32754115
http://dx.doi.org/10.3389/fendo.2020.00381

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7381297/
https://www.ncbi.nlm.nih.gov/pubmed/32754115
http://dx.doi.org/10.3389/fendo.2020.00381

Ejemplares similares